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We have only just begun to decipher the complexity of our brain, including its maturation.
Correct brain development and communication among brain areas are crucial for proper
cognitive behavior. Brain area-speciﬁc genes expressed within a particular time window
direct neurodevelopmental events such as proliferation,migration, axon guidance, dendritic
arborization, and synaptogenesis. These genes can pose as susceptibility factors in neu-
rodevelopmental disorders eventually resulting in area-speciﬁc cognitive deﬁcits.Therefore,
in utero electroporation (IUE)-mediated gene transfer can aid in creating valuable animal
models in which the regionality and time of expression can be restricted for the targeted
gene(s). Moreover, through the use of cell-type-speciﬁc molecular constructs, expression
can be altered in a particular neuronal subsetwithin a distinct area such thatwe are nowable
to causally link the function of that gene in that brain region to the etiology of the disorder.
Thus, IUE-mediated gene transfer is an attractive molecular technique to spatiotemporally
address the developmental aspects of gene function in relation to neurodevelopmental
disorder-associated endophenotypes.
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Our complex adult brain is able to make the daily connections
between areas to present appropriate behavior in response to our
environment. The higher cognitive functions include perception,
attention, memory, problem solving, and emotion, and involves
appropriate cross-talk between neuronal subpopulations in var-
ious brain regions. The development of these brain areas is a
multi-step process that includes proliferation, migration, axon
guidance, dendritic arborization, and synaptogenesis to estab-
lish the correct maturation of the areas and their connectivity.
The various steps in brain area development are guided by a
plethora of molecules that are expressed at a particular place
at a speciﬁc time. To decipher the exact developmental mecha-
nisms that underlie the etiology of neurodevelopmental disorders,
it is necessary to unravel the function of these molecules in four
dimensions.
Linkage and association studies have classiﬁed multiple can-
didate genes that might contribute to the clinical features of
neurodevelopmental disorders. Many of them seem to be involved
in the neurodevelopmental events of brain maturation. Their
exact functions over time and in relation to other genes, how-
ever, remain elusive. Animal models provide compelling insight
into cognitive endophenotypes of these disorders by unraveling
the underlying biological mechanism of the disease (Gould and
Gottesman, 2006; Kellendonk et al., 2009). By introducing molec-
ular ﬂuorescent control and gene target constructs, we are now
able to monitor the mechanisms of (mis)development. Tradi-
tionally, the gene of interest would be molecularly targeted by
homologous recombination, resulting in a systemic absence of the
gene in the animal. However, besides a high level of variability
in the knockout and transgenic lines, often molecular compensa-
tion mechanisms occur. Further, the molecular alteration in the
complete organism shows low construct validity in these com-
plex disorders and even in a Cre–Lox system a large part of the
brain is targeted. For this reason, the innovative and exciting tech-
nique of in utero electroporation (IUE)-mediated gene transfer
is a huge step forward in the research of biological functions of
genes over time, especially in the study of psychiatric disorders
(Fukuchi-Shimogori and Grove, 2001; Inoue and Krumlauf, 2001;
Saito and Nakatsuji, 2001). Major advantages are the spatial and
temporal restriction of gene introduction and the possibility to
target more than one gene suitably at different developmental
time points. Various constructs, either up- or downregulating the
gene of interest, can be microinjected into the lateral ventricles
of the developing embryonic brain. The construct is then incor-
porated into the ventricular surface by electroporation using a
series of unipolar square wave pulses, driving expression into spe-
ciﬁc brain areas in which the position of the positive electrode
deﬁnes the site of DNA entry (Figure 1A). For example, when
the positive pole of the electrodes is positioned dorsally of the
embryonic forebrain, the electroporated area exist of themore dor-
sofrontal brain areas such as the hippocampus (Figures 1A,B,B′)
and prefrontal cortex (PFC; Figures 1A,C,C′). More ventrolateral
positioning of the positive electrode can speciﬁcally electroporate
striatal aspects (Figures 1A,D,D′). By leaving the embryos undis-
turbedduring further development, the timing of examination can
be carefully chosen depending on the question asked. In contrast
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FIGURE 1 | Spatial confinement to areas involved in
neurodevelopmental disorders using in utero electroporation (IUE)
-mediated gene transfer. (A) Schematic representation of IUE into three
areas (1) the hippocampus, (2) the prefrontal cortex, (3) the striatum. On the
left side, a sagittal view is shown indicating the level of the coronal section
(dotted line) shown on the right side where the position of the + and −
poles is indicated. IUE is performed at embryonic day 14.5 (E14.5) and
embryos are left undisturbed for 4 days in utero (diu) before sacriﬁce (sac) at
E18.5. Arrowheads indicate various neurodevelopmental events. (B) E18.5
coronal cryosection of an electroporated mouse brain (E18.5–4diu). Control
construct CMV–YFP–N1 (green) is electroporated into the hippocampal
anlage enlarged in (B′) (boxed area), counterstained with the layer V marker
Ctip2 (red) and ﬂuorescent Nissl (blue). (C) Electroporation was performed
into the whole span of the medial prefrontal cortex (mPFC) including the
infralimbic (IL), prelimbic (PL), and cingulate cortex (Cg). Boxed area is
enlarged in (C′). (D) Electroporation was performed into the ventricular zone
(VZ) of the caudate putamen (CP) close to the external capsule (EC). Boxed
area is enlarged in (D′). CA1, cornu ammonis 1; CA3, cornu ammonis 3; Cg,
cingulate cortex; Ctx, cortex; DG, dentate gyrus; EC, external capsule; Hb,
habenula; Str, striatum.
to the time-consuming generation of transgenic or mutant mouse
lines, thismethod allows for quick analyses of the function of genes
in a spatiotemporal manner.
The ﬁrst major improvement of the technique is the spa-
tial restriction that can be achieved within the developing brain
(Figure 1). Different areas can be aimed for, depending on the
position and/or angle of the positive pole of the electrical square
wave current applied (Figure 1A). This is an improvement to non-
aided in vivo viral infections where the infected area is usually large
and dependent on the titer (Cetin et al., 2006). Areas known to be
involved in neurodevelopmental disorders such as the hippocam-
pus (Nakahira and Yuasa, 2005; Navarro-Quiroga et al., 2007),
PFC, and the striatum can now be reached individually and elec-
troporated with the gene construct(s) of interest (Figures 1A–D′).
In this way, the brain region of interest is affected without dis-
turbing the rest of the embryo. By precisely knocking down a
speciﬁc gene in only the PFC during development, behavioral
abnormalities can be screened postnatally and causal connections
can be made with certain endophenotypes that involve work-
ing memory or information processing (Gould and Gottesman,
2006; Niwa et al., 2010). For example, knocking down DISC1, a
genetic susceptibility factor in schizophrenia, in the PFC using
IUE will lead to particular behavioral deﬁcits in the adult ani-
mal (Niwa et al., 2010). By targeting the ganglionic eminence
or preoptic area, populations of interneurons can be genetically
manipulated (Borrell et al., 2005; Lopez-Bendito et al., 2008; Gel-
man et al., 2009). By speciﬁcally labeling sets of interneurons
by IUE and manipulating GABAergic circuit formation is a big
step forward in neuropsychiatric research as interneurons con-
trol the function of cortical networks implicated to be involved
in the etiology of neurodevelopmental disorders (Fazzari et al.,
2010). The dimension of the transfected area can be adjusted
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by ﬁne-tuning the diameter of the paddle-type electrodes, by
using wire-type electrodes and by altering the time between the
micro-injection of the DNA and the application of the series of
currents. The developmental time point of the micro-injection
extends the range of brain areas to be targeted. The retina, for
example, can be reached by early micro-injection, with or without
facilitation by ultrasound guidance (Garcia-Frigola et al., 2007;
Punzo and Cepko, 2008; Petros et al., 2009a; Punzo et al., 2009).
Thus, any brain (sub)area can currently be targeted, including
areas more difﬁcult to reach such as the midbrain (Alvarez-Maya
et al., 2001; Willett and Greene, 2011), dorsal thalamus (Bonnin
et al.,2007),hypothalamus (Gelmanet al.,2009),amygdala (Reme-
dios et al., 2007; Soma et al., 2009), or rhombic lip/cerebellum
(Kawauchi et al., 2006), by manipulating the timing of intro-
duction, the position of the injection and the position of the
electrodes.
By manipulating the timing of introduction of the construct of
interest (either overexpression or knockdown), various develop-
mental events can be addressed such as proliferation, migration
(both radial as well as tangential), axon guidance, dendritic mat-
uration, and synaptogenesis. One of the ﬁrst studies that used
IUE to examine early patterning of the cerebral cortex by Fgf8
was by the lab of Grove (Fukuchi-Shimogori and Grove, 2001).
Regional patterning was changed such that overexpression of Fgf8
by IUE shifted the position of the somatosensory cortexmore cau-
dal, including occasionally thewhole barrel ﬁeld.When progenitor
cells are electroporated with plasmids directing the overexpression
or knockdown of a target gene, proliferation can be affected which
can be tested in vivo in combination with the use of BrdU which
incorporates into the S-phase of dividing cells (Figures 2A,B).
For instance, when the forward signaling of the receptor tyro-
sine kinase EphA4 is diminished in cortical progenitors through
IUE by introducing a dominant-negative EphA4 construct lacking
the kinase domain, cell division is affected (North et al., 2009).
Another developmental event that can be studied through the
use of IUE is neuronal migration (Figures 2C–F). This is par-
ticularly apparent in the “inside-out” layering of the cerebral
cortex where late-born neurons migrate to their more superﬁ-
cial positions past the early born neurons in the deeper layers.
Defects in migration can thus result in aberrant layering or even
heterotopias (Kawauchi et al., 2003; Bai et al., 2008). Using layer-
speciﬁc markers along with BrdU to “birthdate” cells in com-
bination with IUE, defects in migration can be easily detected
(Figures 2D–F). Early axon guidance events can be altered by
either molecularly changing the target area or the area where
the projections originate from (Figures 2G,H). Knocking down
the levels of Disc1 in a speciﬁc subset of pyramidal neurons in
the developing mouse PFC actually diminishes the dopaminergic
mesocortical projections leading to prominent behavioral prob-
lems in adulthood (Niwa et al., 2010). Also it was shown that
ectopic EphB1 expression in a subset of retinal ganglion cells estab-
lished using IUE convincingly altered their projection trajectory
(Petros et al., 2009b). Also, the later events in development such as
Fgf8 dendritic arborization and connectivity can be studied using
IUE (Figures 2I,J). The molecular mechanisms underlying late
neurodevelopmental events such as synaptogenesis and synapse
maturation can be examined by introducing the plasmid early
and analyzing the brain areas of interest postnatally (Elias et al.,
2008). Furthermore, a developmentally very late electroporation
paradigm (at E18.5 or postnatal) can be performed and will drive
expression in mainly the astrocytic progenitors (LoTurco et al.,
2009).
To manipulate gene expression, constructs can be designed
to target speciﬁc cells at a speciﬁc time (Miyagi et al., 2004;
Gal et al., 2006; Wang et al., 2007b). Experiments using IUE
can be performed using either knockdown by RNA interference
(RNAi), antisense morpholinos, dominant-negative (DN; North
et al., 2009) constructs, or toxins (Wang et al., 2007a) to manip-
ulate cell signaling, or a Cre–Lox system to ﬁne-tune expression
time or combinations of constructs in which a full-length (FL)
version is later used to rescue a particular phenotype (Mizutani
and Saito, 2005; Matsuda and Cepko, 2007). The high capacity
and efﬁciency of viral vectors makes them suitable for the over-
expression of large full-length constructs but can however elicit
immune responses in the adult brain (Davidson and Breakeﬁeld,
2003; Cetin et al., 2006). The downside of non-viral vectors on the
other hand is that they are expected to be preserved episomally
and thus not suitable for lineage trace experiments. Promoters
such as the cytomegalovirus (CMV) and elongation factor 1α
(EF1α) are not cell-type-speciﬁc and yield moderate expression
levels that persist after birth and can therefore be used to study
various developmental events (Figure 3). A battery of ﬂuores-
cent elements can be either incorporated into the construct or
co-electroporated with another construct to visualize the expres-
sion pattern (Figures 3A,B). Nowadays the most commonly used
knockdown construct is the micro-RNA30-based short hairpin
RNA (shRNA) for RNAi under the ubiquitous polymerase II pro-
moter like chicken actin (CAG; Figure 3C). The knockdown of
doublecortin-like (DCL) for example resulted in a reduced pro-
liferation of neurons and radial glia ﬁber instability (Vreugdenhil
et al., 2007). Distinct neurodevelopmental events in a subset of
neurons within a particular region can now be controlled using
cell-type-speciﬁc regulatory elements (Matsuda and Cepko, 2007;
LoTurco et al., 2009; Manent et al., 2009). Cell-type-speciﬁc pro-
moter or regulatory elements such as Thy1, Nestin, Tα1, BLBP,
PDGF, GLAST (Gal et al., 2006), CAMKII, Synapsin, DCX (Wang
et al., 2007b), NSE but also ER81 and Ngn2 (Langevin et al.,
2007) can drive expression of a ﬂuorescently labeled construct
into a particular neuronal cell population in which the time of
expression can be both dependent on the time of electropo-
ration and the period of expression of the regulatory element
(Figure 3A). In this way endophenotypes can be further unrav-
eled because of the speciﬁcity of the gene manipulation. To dis-
sect gene–gene interaction, multiple constructs of different genes
can be electroporated at the same time which is again a great
step ahead in deciphering the molecular pathways underlying
cognitive deﬁcits associated with neurodevelopmental disorders
(Kamiya, 2009). Neuronal migration is often affected in these
disorders and Young-Pearse et al. (2007) showed that the effect
on migration, by knocking down APP and Dab1, could be later
recued using overexpression of Dab1. Likewise, when RNAi of
Lis1 and dynein mutants where expressed at the same time their
dual role in neuronal migration could be unraveled (Tsai et al.,
2007).
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FIGURE 2 |Temporal restriction of gene introduction during various
neurodevelopmental events. (A) Schematic representation of the
proliferation paradigm using in utero electroporation (IUE). Two hours prior to
sacriﬁce (sac), BrdU is injected to label dividing cells. (B) E15.5 coronal
section showing the cerebral cortex with in red the BrdU-labeled cells within
the proliferative zone (PZ) and in green the CMV–YFP–N1 construct (YFP),
counterstained with ﬂuorescent Nissl (blue) 1 day after IUE (1 diu). (C)
Confocal image ofYFP-labeled neurons and radial glia (green) co-stained with
the radial glia marker RC2 (red). Arrowhead indicates a migrating neuron
“climbing the robe” of a radial glia. (D) Schematic representation of the
migration paradigm using IUE. Just after surgery BrdU is injected to label
dividing cells and “birthdate” them. (E) E17.5 coronal section showing the
cerebral cortex with BrdU-labeled cells (red) that have migrated to a certain
position within the cortical plate (CP) combined with aYFP control construct
(green), counterstained with ﬂuorescent Nissl (blue) 3 days after IUE (3 diu).
As soon as theYFP-positive neurons become post-mitotic they start to
migrate and can be double labeled with BrdU (yellow). (F) Is an enlargement
of the boxed area in (E). (G) E18.5 coronal section showing anYFP-labeled
(green) somatosensory cortex (S1) projecting toward the other hemisphere
through the corpus callosum (CC) counterstained with superﬁcial layer marker
Satb2 (red) and ﬂuorescent Nissl (blue). (H) Is an enlargement of the
projections through the CC in (G). (I) P24 coronal section showing
YFP-positive pyramidal neurons (green) in layer IV of the S1 on top of the layer
V marker Ctip2 (red). (J) Network formation of YFP-positive pyramidal neurons
with extended dendritic branches and axonal projections. Counterstained with
Ctip2 (red) en ﬂuorescent Nissl (blue).
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FIGURE 3 | Constructs for use in in utero electroporation (IUE) to
direct expression in a four-dimensional way. (A) Schematic
representation of the most frequently used constructs that can be
constitutively expressed under either a ubiquitous promoter (e.g., CMV,
cytomegalovirus; EF1, elongation factor 1; ROSA, ROSA26TATA-less
promoter; CAG, chicken actin combined with CMV enhancer) or a
cell-type-speciﬁc promoter (e.g., Thy1, THYmocyte differentiation
antigen 1 driving expression in axons of neurons; Nestin, neuronal
stem cell tubulin neuronal promoter; Tα1, α-tubulin neuronal promoter;
BLBP, brain lipid-binding protein radial glial speciﬁc promoter; GLAST,
glutamate–aspartate transporter radial glial/astrocytic promoter;
CAMKII, calcium/calmodulin-dependent kinase II neuronal promoter
speciﬁc for forebrain; Synapsin, neuronal promoter; DCX, doublecortin
neuroblast-speciﬁc promoter; NSE, neuron-speciﬁc enolase drives
expression in neurons and to some extent in glial cells; ER81, ETS
family transcription factor driving expression in speciﬁc subset of
neurons; Ngn2, neurogenin2 driving expression in neurons; TH,
tyrosine hydroxylase dopaminergic neuron-speciﬁc promoter). These
promoters can drive expression of among others full-length (FL)
constructs, dominant-negative (DN) constructs or, e.g., shRNAs of
genes of interest (GOI) to establish knockdown via RNAi. The reporter
element can be either a ﬂuorescent protein ranging from far red, red,
orange, yellow, green, or cyan ﬂuorescence or LacZ. Often enhancer
elements (e.g., SV40, NFkB, NFAT, ISRE, or p53) are used, but this is
not always essential to drive the expression. Electroporation constructs
are all terminated with a polyA tail. (B) Schematic representation of the
commonly used inducible constructs such as the Cre-reporter construct
expressed under an ubiquitous or a cell-type-speciﬁc promoter. The
GOI containing construct can be under the control of an ubiquitous
promoter (usually CAG) a neomycin (neo)-cassette that is ﬂoxed (loxP
before and after) and thus excised upon addition of tamoxifen at a
speciﬁc time point in development. (C) Example of a knockdown
experiment using IUE with an off-target construct (control) and RNAi
against the doublecortin-like gene (pSuper-DCL183 or DCLi). Both in
the proliferative zone (PZ) as well as in the intermediate zone (IZ) and
cortical plate (CP) neurons are reduced in number and the radial ﬁbers
are severely disrupted. Green is the construct, red is a β-tubulin
staining (Tuj1). Adapted from Vreugdenhil et al. (2007).
Inducible models generated through the use of IUE have
opened a new dimension to study the complexity of gene func-
tion(s) in the development of brain areas. The Cre–LoxP system
can be used in combination with the ubiquitous CAG promoter or
with above-mentioned regulatory elements that will allow expres-
sion in only a subset of neurons in a particular area and in a
speciﬁc, carefully chosen time window through administration of
tamoxifen inducing the Cre–ER(T) recombinases (Figure 3B). In
this way, the onset of gene expression/suppression can bemanipu-
lated, for example at the peak of postnatal synaptogenesis avoiding
the effect of this particular gene targeting on earlier events like
neurogenesis or migration (Mizutani and Saito, 2005). Such an
inducible system can furthermore be used in conjunction with
the formerly performed effective RNAi-based knockdown where
a possible rescue can be put in place postnatally (Matsuda and
Cepko, 2007).
Together, IUE-mediated gene transfer has shown to be an
exceptional powerful tool to create animal models in which both
the spatial as well as the temporal aspects of gene expression
can be manipulated. In future studies, adjustments like dif-
ferent sizes and shapes of the electrodes will further enhance
the ability to speciﬁcally target a (sub)area. Inducible systems
using chemical agents or optogenetic light-sensitive constructs
such as channel-or halorhodopsin-assisted IUE (Petreanu et al.,
2007; Lewis et al., 2009; Zhang et al., 2010) will further restrict
the expression window in space and time, and thus a more
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precise control of gene manipulations can be achieved. Com-
bined with the use of constructs containing regulatory ele-
ments that drive expression in not only a temporally way but
also in an area-, layer-, and neuronal cell population-speciﬁc
manner will greatly enhance our knowledge of the functions
of particular susceptibility genes playing a role in brain area-
speciﬁc cognitive deﬁcits associated with neurodevelopmental
disorders.
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